Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gil

Showing results (311-320 of 328) with videos related to

Pageof 33
Sort By:
Neurologia|December 26, 2025
How do we face the challenges of the Spanish Society of Neurology? Strategic Plan of the Spanish Society of NeurologyJ M Láinez Andrés, C Íñiguez Martínez, J Porta Etessam, et al.
Clinical Colorectal Cancer|March 21, 2023
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized TrialsP Jiménez-Fonseca, J Sastre, P García-Alfonso, et al.
Journal of Photochemistry and Photobiology. B, Biology|May 22, 2016
Photoprotective effect and acute oral systemic toxicity evaluation of the novel heterocyclic compound LQFM048Daniela C Vinhal, Renato Ivan de Ávila, Marcelo S Vieira, et al.
ESMO Open|March 12, 2021
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 studyJ Sastre, P García-Alfonso, J M Viéitez, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 21, 2017
A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activityAdriane F Brito, Patrícia C C S Braga, Lorrane K S Moreira, et al.
Ecohealth|April 3, 2026
First Report of Human Hepatitis B Virus (HBV) in Wild Neotropical PrimatesJean P Boubli, Hani Rocha El Bizri, Luan F Botelho-Souza, et al.
International Journal of Obesity (2005)|December 30, 2022
Exercise modifies hypothalamic connectivity and brain functional networks in women after bariatric surgery: a randomized clinical trialCarlos A A Merege-Filho, Saulo S Gil, John P Kirwan, et al.
Cancer Research|April 6, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate CancerAlec Paschalis, Jonathan Welti, Antje J Neeb, et al.
Placenta|February 24, 2015
IFPA meeting 2014 workshop report: Animal models to study pregnancy pathologies; new approaches to study human placental exposure to xenobiotics; biomarkers of pregnancy pathologies; placental genetics and epigenetics; the placenta and stillbirth and fetal growth restrictionS Barbaux, J J H M Erwich, P O Favaron, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
Pageof 33

Showing results (311-320 of 328) with videos related to

Sort By:
Pageof 33
Neurologia|December 26, 2025
How do we face the challenges of the Spanish Society of Neurology? Strategic Plan of the Spanish Society of NeurologyJ M Láinez Andrés, C Íñiguez Martínez, J Porta Etessam, et al.
Clinical Colorectal Cancer|March 21, 2023
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized TrialsP Jiménez-Fonseca, J Sastre, P García-Alfonso, et al.
Journal of Photochemistry and Photobiology. B, Biology|May 22, 2016
Photoprotective effect and acute oral systemic toxicity evaluation of the novel heterocyclic compound LQFM048Daniela C Vinhal, Renato Ivan de Ávila, Marcelo S Vieira, et al.
ESMO Open|March 12, 2021
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 studyJ Sastre, P García-Alfonso, J M Viéitez, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 21, 2017
A new piperazine derivative: 1-(4-(3,5-di-tert-butyl-4-hydroxybenzyl) piperazin-1-yl)-2-methoxyethan-1-one with antioxidant and central activityAdriane F Brito, Patrícia C C S Braga, Lorrane K S Moreira, et al.
Ecohealth|April 3, 2026
First Report of Human Hepatitis B Virus (HBV) in Wild Neotropical PrimatesJean P Boubli, Hani Rocha El Bizri, Luan F Botelho-Souza, et al.
International Journal of Obesity (2005)|December 30, 2022
Exercise modifies hypothalamic connectivity and brain functional networks in women after bariatric surgery: a randomized clinical trialCarlos A A Merege-Filho, Saulo S Gil, John P Kirwan, et al.
Cancer Research|April 6, 2021
JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate CancerAlec Paschalis, Jonathan Welti, Antje J Neeb, et al.
Placenta|February 24, 2015
IFPA meeting 2014 workshop report: Animal models to study pregnancy pathologies; new approaches to study human placental exposure to xenobiotics; biomarkers of pregnancy pathologies; placental genetics and epigenetics; the placenta and stillbirth and fetal growth restrictionS Barbaux, J J H M Erwich, P O Favaron, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
Pageof 33